Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates.

ABSTRACT:

Background

A pressing need exists to develop vaccines for neglected diseases, including leishmaniasis. However, the development of new vaccines is dependent on their value to two key players-vaccine developers and manufacturers who need to have confidence in the global demand in order to commit to research and production; and governments (or other international funders) who need to signal demand based on the potential public health benefits of the vaccine in their local context, as well as its affordability. A detailed global epidemiological analysis is rarely available before a vaccine enters a market due to lack of resources as well as insufficient global data necessary for such an analysis. Our study seeks to bridge this information gap by providing a generalisable approach to e

SUBMITTER: Mohan S 

PROVIDER: S-EPMC9232160 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature